Iovance Biotherapeutics, Inc. (IOVA)
3.56
-0.14
(-3.78%)
USD |
NASDAQ |
May 12, 16:00
3.57
+0.01
(+0.28%)
Pre-Market: 09:09
Iovance Biotherapeutics Free Cash Flow : -305.02M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| KalVista Pharmaceuticals, Inc. | -- |
| Anika Therapeutics, Inc. | 1.039M |
| BioCryst Pharmaceuticals, Inc. | 293.05M |
| Plus Therapeutics, Inc. | -20.84M |
| Perspective Therapeutics, Inc. | -107.53M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -72.07M |
| Cash from Investing (Quarterly) | 11.39M |
| Cash from Financing (Quarterly) | 94.34M |
| Free Cash Flow Per Share (Quarterly) | -0.188 |
| Free Cash Flow to Equity (Quarterly) | -77.01M |
| Free Cash Flow to Firm (Quarterly) | -78.68M |
| Free Cash Flow Yield | -22.49% |